A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Meira G Tx Holdings PLC stock. As of the latest transaction made, Citadel Advisors LLC holds 19,200 shares of MGTX stock, worth $120,576. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,200
Previous 24,200 20.66%
Holding current value
$120,576
Previous $101,000 20.79%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.88 - $5.23 $66,770 - $90,003
-17,209 Reduced 7.89%
200,833 $837,000
Q2 2024

Aug 14, 2024

BUY
$4.21 - $5.81 $629,870 - $869,251
149,613 Added 218.64%
218,042 $917,000
Q1 2024

May 15, 2024

SELL
$5.78 - $7.33 $970,386 - $1.23 Million
-167,887 Reduced 71.04%
68,429 $415,000
Q4 2023

Feb 14, 2024

BUY
$3.6 - $7.15 $728,398 - $1.45 Million
202,333 Added 595.39%
236,316 $1.66 Million
Q3 2023

Nov 14, 2023

SELL
$4.79 - $7.19 $26,100 - $39,178
-5,449 Reduced 13.82%
33,983 $166,000
Q2 2023

Aug 14, 2023

BUY
$5.19 - $8.07 $2,179 - $3,389
420 Added 1.08%
39,432 $264,000
Q1 2023

May 15, 2023

SELL
$5.04 - $8.6 $24,811 - $42,337
-4,923 Reduced 11.21%
39,012 $201,000
Q4 2022

Feb 14, 2023

SELL
$5.8 - $8.98 $2,760 - $4,274
-476 Reduced 1.07%
43,935 $286,000
Q3 2022

Nov 14, 2022

SELL
$7.55 - $11.25 $232,660 - $346,680
-30,816 Reduced 40.96%
44,411 $373,000
Q2 2022

Aug 15, 2022

SELL
$6.8 - $14.23 $181,104 - $378,987
-26,633 Reduced 26.15%
75,227 $569,000
Q1 2022

May 16, 2022

BUY
$13.42 - $23.38 $344,115 - $599,509
25,642 Added 33.64%
101,860 $1.41 Million
Q4 2021

Feb 14, 2022

BUY
$12.78 - $23.74 $615,778 - $1.14 Million
48,183 Added 171.87%
76,218 $0
Q3 2021

Nov 15, 2021

BUY
$11.73 - $16.08 $154,519 - $211,821
13,173 Added 88.64%
28,035 $369,000
Q1 2021

May 17, 2021

SELL
$13.84 - $17.8 $1.07 Million - $1.38 Million
-77,361 Reduced 83.88%
14,862 $215,000
Q4 2020

Feb 16, 2021

BUY
$12.4 - $17.6 $209,820 - $297,809
16,921 Added 22.47%
92,223 $1.4 Million
Q3 2020

Nov 16, 2020

SELL
$11.59 - $14.93 $204,262 - $263,126
-17,624 Reduced 18.97%
75,302 $997,000
Q2 2020

Aug 14, 2020

BUY
$11.79 - $15.97 $360,715 - $488,602
30,595 Added 49.08%
92,926 $1.16 Million
Q1 2020

May 15, 2020

SELL
$9.31 - $21.24 $100,352 - $228,945
-10,779 Reduced 14.74%
62,331 $837,000
Q4 2019

Feb 14, 2020

BUY
$13.91 - $21.48 $334,243 - $516,142
24,029 Added 48.96%
73,110 $1.46 Million
Q3 2019

Nov 14, 2019

BUY
$15.84 - $30.01 $777,443 - $1.47 Million
49,081 New
49,081 $0

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $283M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.